Peter M. Doubilet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter M. Doubilet has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Carol B. Benson
5 shared publications- Carol B. Benson
Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts USA
4 shared publications - Andrei V. Alexandrov
Department of Neurology, University of Arizona, Phoenix
1 shared publication Brian J. Burke
1 shared publication- Darius G. Nabavi
Klinik für Neurologie mit Stroke Unit, Vivantes Klinikum Neukölln, Berlin, Deutschland
1 shared publication Dennis Bandyk
1 shared publication
Latest Publications
- 1 November 2014
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 52 (6) , 1191-1199
Ultrasound Evaluation of the First Trimester
- 1 November 2014
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 52 (6) , 1191-1199
Ultrasound Evaluation of the First Trimester
- Top Cited Papers
- 10 October 2013
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 369 (15) , 1443-1451
Diagnostic Criteria for Nonviable Pregnancy Early in the First Trimester
Determining the viability of a pregnancy is a major challenge, especially with a pregnancy of unknown location. This review provides specific guidance, including stringent criteria for nonviability, that can reduce the risk of inadvertent harm to a potentially normal pregnancy.
- 10 October 2013
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 369 (15) , 1443-1451
Top Cited PapersDiagnostic Criteria for Nonviable Pregnancy Early in the First Trimester
Determining the viability of a pregnancy is a major challenge, especially with a pregnancy of unknown location. This review provides specific guidance, including stringent criteria for nonviability, that can reduce the risk of inadvertent harm to a potentially normal pregnancy.
- 1 October 2013
- Published by Elsevier in Seminars in Perinatology
- Vol. 37 (5) , 307-309
Should a first trimester dating scan be routine for all pregnancies?
- 1 October 2013
- Published by Elsevier in Seminars in Perinatology
- Vol. 37 (5) , 307-309
Should a first trimester dating scan be routine for all pregnancies?
- 1 July 2013
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (7) , 1207-1214
Double Sac Sign and Intradecidual Sign in Early Pregnancy
Objectives: To assess the interobserver agreement, frequency of occurrence, and prognostic importance of the double sac sign (DSS), intradecidual sign (IDS), and other sonographic findings in early intrauterine pregnancies.Methods: We retrospectively identified all sonograms obtained between January 1, 2006, and December 31, 2011, in which: (1) the scan demonstrated an intrauterine fluid collection without a yolk sac or embryo; (2) a follow‐up scan confirmed an intrauterine pregnancy; and (3) the first‐trimester outcome was known. Each coinvestigator characterized the 199 study sonograms as demonstrating or not demonstrating a DSS or an IDS, based on judgment about whether the scan met published criteria defining these signs.Results: Interobserver agreement was poor for the DSS (κ= 0.24) and IDS (κ= 0.23). Scans frequently demonstrated neither sign: 150 cases (75.4%) if we considered a sign to be present when both investigators graded it as present and 69 cases (34.7%) using the looser criterion that either graded it as present. The presence of a DSS or an IDS was unrelated to the β‐human chorionic gonadotropin (β‐hCG) value (P > .05, t test, all comparisons). An inner echogenic ring was present in 158 cases (79.4%), and the decidua was brighter peripherally than centrally in 102 (51.3%). The first‐trimester outcome was unrelated to the presence of a DSS or an IDS, presence of an inner echogenic ring, or decidual appearance (P > .05, χ2, all comparisons).Conclusions: The sonographic appearance of early gestational sacs, before visualization of a yolk sac or embryo, is highly variable. The DSS and IDS are often absent; there is poor interobserver agreement regarding these signs; and the prognosis is unrelated to their presence or absence. A round or oval intrauterine fluid collection in a woman with positive β‐hCG should be treated as a gestational sac until proven otherwise, regardless of whether it demonstrates a DSS or an IDS.
- 1 July 2013
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (7) , 1207-1214
Double Sac Sign and Intradecidual Sign in Early Pregnancy
Objectives: To assess the interobserver agreement, frequency of occurrence, and prognostic importance of the double sac sign (DSS), intradecidual sign (IDS), and other sonographic findings in early intrauterine pregnancies.Methods: We retrospectively identified all sonograms obtained between January 1, 2006, and December 31, 2011, in which: (1) the scan demonstrated an intrauterine fluid collection without a yolk sac or embryo; (2) a follow‐up scan confirmed an intrauterine pregnancy; and (3) the first‐trimester outcome was known. Each coinvestigator characterized the 199 study sonograms as demonstrating or not demonstrating a DSS or an IDS, based on judgment about whether the scan met published criteria defining these signs.Results: Interobserver agreement was poor for the DSS (κ= 0.24) and IDS (κ= 0.23). Scans frequently demonstrated neither sign: 150 cases (75.4%) if we considered a sign to be present when both investigators graded it as present and 69 cases (34.7%) using the looser criterion that either graded it as present. The presence of a DSS or an IDS was unrelated to the β‐human chorionic gonadotropin (β‐hCG) value (P > .05, t test, all comparisons). An inner echogenic ring was present in 158 cases (79.4%), and the decidua was brighter peripherally than centrally in 102 (51.3%). The first‐trimester outcome was unrelated to the presence of a DSS or an IDS, presence of an inner echogenic ring, or decidual appearance (P > .05, χ2, all comparisons).Conclusions: The sonographic appearance of early gestational sacs, before visualization of a yolk sac or embryo, is highly variable. The DSS and IDS are often absent; there is poor interobserver agreement regarding these signs; and the prognosis is unrelated to their presence or absence. A round or oval intrauterine fluid collection in a woman with positive β‐hCG should be treated as a gestational sac until proven otherwise, regardless of whether it demonstrates a DSS or an IDS.
- 1 May 2012
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 31 (5) , 817-818
Reply
- Open Access
- 1 December 2011
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 30 (12) , 1637-1642
Further Evidence Against the Reliability of the Human Chorionic Gonadotropin Discriminatory Level
Objectives: The human chorionic gonadotropin (hCG) discriminatory level—the maternal serum β‐hCG level above which a gestational sac should be consistently visible on sonography in a normal pregnancy—has been reported to be 1000 to 2000 mIU/mL for transvaginal sonography. We assessed whether a woman with a β‐hCG above 2000 mIU/mL and no intrauterine fluid collection on transvaginal sonography can subsequently be found to have a live intrauterine gestation and, if so, what the prognosis is for the pregnancy.Methods: We identified all women scanned between January 1, 2000, and December 31, 2010, who met the following criteria: serum β‐hCG testing and transvaginal sonography were performed on the same day; β‐hCG was positive and sonography showed no intrauterine fluid collection; and a live intrauterine pregnancy was subsequently documented. We tabulated the β‐hCG levels in these cases and assessed pregnancy outcome.Results: A total of 202 patients met the inclusion criteria, including 162 (80.2%) who had β‐hCG levels below 1000 mIU/mL on the day of the initial scan showing no intrauterine fluid collection, 19 (9.4%) with levels of 1000 to 1499, 12 (5.9%) 1500 to 1999, and 9 (4.5%) above 2000 mIU/mL. There was no significant relationship between initial β‐hCG level and either first‐trimester outcome or final pregnancy outcome (P > .05, logistic regression analysis and Fisher exact test). The highest β‐hCG was 6567 mIU/mL, and the highest value that preceded a liveborn term baby was 4336 mIU/mL.Conclusions: The hCG discriminatory level should not be used to determine the management of a hemodynamically stable patient with suspected ectopic pregnancy, if sonography demonstrates no findings of intrauterine or ectopic pregnancy.
- 1 December 2011
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 30 (12) , 1637-1642
Open AccessFurther Evidence Against the Reliability of the Human Chorionic Gonadotropin Discriminatory Level
Objectives: The human chorionic gonadotropin (hCG) discriminatory level—the maternal serum β‐hCG level above which a gestational sac should be consistently visible on sonography in a normal pregnancy—has been reported to be 1000 to 2000 mIU/mL for transvaginal sonography. We assessed whether a woman with a β‐hCG above 2000 mIU/mL and no intrauterine fluid collection on transvaginal sonography can subsequently be found to have a live intrauterine gestation and, if so, what the prognosis is for the pregnancy.Methods: We identified all women scanned between January 1, 2000, and December 31, 2010, who met the following criteria: serum β‐hCG testing and transvaginal sonography were performed on the same day; β‐hCG was positive and sonography showed no intrauterine fluid collection; and a live intrauterine pregnancy was subsequently documented. We tabulated the β‐hCG levels in these cases and assessed pregnancy outcome.Results: A total of 202 patients met the inclusion criteria, including 162 (80.2%) who had β‐hCG levels below 1000 mIU/mL on the day of the initial scan showing no intrauterine fluid collection, 19 (9.4%) with levels of 1000 to 1499, 12 (5.9%) 1500 to 1999, and 9 (4.5%) above 2000 mIU/mL. There was no significant relationship between initial β‐hCG level and either first‐trimester outcome or final pregnancy outcome (P > .05, logistic regression analysis and Fisher exact test). The highest β‐hCG was 6567 mIU/mL, and the highest value that preceded a liveborn term baby was 4336 mIU/mL.Conclusions: The hCG discriminatory level should not be used to determine the management of a hemodynamically stable patient with suspected ectopic pregnancy, if sonography demonstrates no findings of intrauterine or ectopic pregnancy.
- 1 April 2011
- Published by Wolters Kluwer Health in Menopause
- Vol. 18 (4) , 424-427
Diagnosis of abnormal uterine bleeding with imaging
The major role of ultrasound in the evaluation of abnormal uterine bleeding, other than that occurring during pregnancy, is in postmenopausal women. Because postmenopausal bleeding can be the presenting symptom of endometrial cancer, any woman with this symptom should be evaluated to diagnose or exclude carcinoma. Over the last two decades, the role of ultrasound in the evaluation of postmenopausal bleeding has changed markedly, from little or no role in 1990 to a major role today. In the intervening years, numerous studies have shown that ultrasound is at least as sensitive as endometrial biopsy for endometrial cancer and that ultrasound can reliably exclude cancer without the need for biopsy in some women with postmenopausal bleeding. In particular, numerous studies have shown that women with an endometrial thickness of 4 mm or less have an extremely low likelihood of endometrial cancer and thus do not need to undergo endometrial biopsy. Ultrasound can also help in the selection of an appropriate biopsy technique. In a woman with postmenopausal bleeding and a thick endometrium, a sonohysterogram can determine whether the endometrium is diffusely thick or has focal areas of thickening. With diffuse thickening, a blind endometrial biopsy is appropriate. When there are one or more focal areas of thickening, hysteroscopic biopsy is likely to be the better choice. We present two clinical algorithms, either of which is an acceptable approach to the use of ultrasound and/or endometrial biopsy in women with postmenopausal bleeding: the "ultrasound-first" approach and the "biopsy-first" approach.
- 1 April 2011
- Published by Wolters Kluwer Health in Menopause
- Vol. 18 (4) , 424-427
Diagnosis of abnormal uterine bleeding with imaging
The major role of ultrasound in the evaluation of abnormal uterine bleeding, other than that occurring during pregnancy, is in postmenopausal women. Because postmenopausal bleeding can be the presenting symptom of endometrial cancer, any woman with this symptom should be evaluated to diagnose or exclude carcinoma. Over the last two decades, the role of ultrasound in the evaluation of postmenopausal bleeding has changed markedly, from little or no role in 1990 to a major role today. In the intervening years, numerous studies have shown that ultrasound is at least as sensitive as endometrial biopsy for endometrial cancer and that ultrasound can reliably exclude cancer without the need for biopsy in some women with postmenopausal bleeding. In particular, numerous studies have shown that women with an endometrial thickness of 4 mm or less have an extremely low likelihood of endometrial cancer and thus do not need to undergo endometrial biopsy. Ultrasound can also help in the selection of an appropriate biopsy technique. In a woman with postmenopausal bleeding and a thick endometrium, a sonohysterogram can determine whether the endometrium is diffusely thick or has focal areas of thickening. With diffuse thickening, a blind endometrial biopsy is appropriate. When there are one or more focal areas of thickening, hysteroscopic biopsy is likely to be the better choice. We present two clinical algorithms, either of which is an acceptable approach to the use of ultrasound and/or endometrial biopsy in women with postmenopausal bleeding: the "ultrasound-first" approach and the "biopsy-first" approach.
- 1 August 2005
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 236 (2) , 643-646
Outcome of First-Trimester Pregnancies with Slow Embryonic Heart Rate at 6–7 Weeks Gestation and Normal Heart Rate by 8 Weeks at US
To determine retrospectively the outcome of pregnancies in which the embryo has a slow heart rate at 6.0-7.0 weeks gestation and a normal heart rate at follow-up ultrasonography (US) by 8.0 weeks gestation. Institutional review board approval was granted; informed consent was not required. The study was Health Insurance Portability and Accountability Act compliant. Singleton pregnancies with an embryonic heart rate measured on a 6.0-7.0-week US scan were identified. The heart rate was classified as slow if it was fewer than 90 beats per minute prior to 6.3 weeks or fewer than 110 beats/min at 6.3-7.0 weeks, normal if it was 100 or more beats/min at less than 6.3 weeks or 120 or more beats/min at 6.3-7.0 weeks, or borderline if it was 90-99 beats/min prior to 6.3 weeks or 110-119 beats/min at 6.3-7.0 weeks. Pregnancies were excluded from the analysis if they were lost to follow-up before the end of first trimester. The Fisher exact test was used for all statistical comparisons. The rates of first-trimester demise were 60.6% for pregnancies with slow heart rates at 6.0-7.0 weeks (188 of 310), 17.4% for those with borderline heart rates (103 of 593), and 9.1% for those with normal heart rates (186 of 2034). There were 59 pregnancies with a slow heart rate at 6.0-7.0 weeks and a normal heart rate at follow-up US by 8.0 weeks; 15 (25.4%) resulted in first-trimester demise. This rate of demise was significantly higher than that of 7.2% (28 of 390) in pregnancies with a normal heart rate at 6.0-7.0 weeks and a normal heart rate by 8.0 weeks (P <.001, Fisher exact test). Pregnancies with a borderline heart rate early in pregnancy followed by a normal heart rate had a demise rate of 7.6% (nine of 118), which is similar to those with normal heart rates early in pregnancy followed by normal heart rates at follow-up (P = .84). When a slow embryonic heart rate is detected at 6.0-7.0 weeks, the likelihood of subsequent first-trimester demise remains elevated (approximately 25%) even if the heart rate is normal at follow-up. In such pregnancies, at least one follow-up scan in late first trimester is warranted.
- 1 August 2005
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 236 (2) , 643-646
Outcome of First-Trimester Pregnancies with Slow Embryonic Heart Rate at 6–7 Weeks Gestation and Normal Heart Rate by 8 Weeks at US
To determine retrospectively the outcome of pregnancies in which the embryo has a slow heart rate at 6.0-7.0 weeks gestation and a normal heart rate at follow-up ultrasonography (US) by 8.0 weeks gestation. Institutional review board approval was granted; informed consent was not required. The study was Health Insurance Portability and Accountability Act compliant. Singleton pregnancies with an embryonic heart rate measured on a 6.0-7.0-week US scan were identified. The heart rate was classified as slow if it was fewer than 90 beats per minute prior to 6.3 weeks or fewer than 110 beats/min at 6.3-7.0 weeks, normal if it was 100 or more beats/min at less than 6.3 weeks or 120 or more beats/min at 6.3-7.0 weeks, or borderline if it was 90-99 beats/min prior to 6.3 weeks or 110-119 beats/min at 6.3-7.0 weeks. Pregnancies were excluded from the analysis if they were lost to follow-up before the end of first trimester. The Fisher exact test was used for all statistical comparisons. The rates of first-trimester demise were 60.6% for pregnancies with slow heart rates at 6.0-7.0 weeks (188 of 310), 17.4% for those with borderline heart rates (103 of 593), and 9.1% for those with normal heart rates (186 of 2034). There were 59 pregnancies with a slow heart rate at 6.0-7.0 weeks and a normal heart rate at follow-up US by 8.0 weeks; 15 (25.4%) resulted in first-trimester demise. This rate of demise was significantly higher than that of 7.2% (28 of 390) in pregnancies with a normal heart rate at 6.0-7.0 weeks and a normal heart rate by 8.0 weeks (P <.001, Fisher exact test). Pregnancies with a borderline heart rate early in pregnancy followed by a normal heart rate had a demise rate of 7.6% (nine of 118), which is similar to those with normal heart rates early in pregnancy followed by normal heart rates at follow-up (P = .84). When a slow embryonic heart rate is detected at 6.0-7.0 weeks, the likelihood of subsequent first-trimester demise remains elevated (approximately 25%) even if the heart rate is normal at follow-up. In such pregnancies, at least one follow-up scan in late first trimester is warranted.
- 1 January 2005
- Published by Elsevier
Contributors